Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global influenza vaccine market reached a value of US$ 5.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Influenza vaccines, also known as flu shots, provide protection against various types of influenza viruses. They are available in several options, including inactivated influenza vaccine [IIV], recombinant influenza vaccine [RIV], and live attenuated influenza vaccine (LAIV). Their effectiveness can vary, depending on the patient's age and health status. Presently, governments of numerous countries have mandated immunization against influenza among children between six months and five years of age. This is escalating the need for influenza vaccines to reduce the high risk of developing severe flu complications and hospitalization among infants around the world.
Influenza Vaccine Market Trends:
The rising prevalence of diabetes, cancer, anemia, obesity, immune deficiencies, human immunodeficiency virus (HIV), metabolic diseases, kidney disease, neurological disorder, and chronic heart and lung disorders, such as bronchopulmonary dysplasia, cystic fibrosis, and asthma, is increasing the risk of developing influenza. This acts as a major factor bolstering the market growth. In addition, children under five years of age are usually at a high risk of complications from high fever, convulsions, and pneumonia. This, in confluence with growing concerns among parents about the well-being of their children, is positively influencing the demand for influenza vaccines. Moreover, as immune systems decline with age, the rising geriatric population worldwide is catalyzing the demand for influenza vaccines to prevent serious illness, the need for hospitalization, and the possibility of a heart attack. Several vaccines are also available that help boost immune response in adults over sixty-five years. Besides this, health agencies of numerous countries are introducing free seasonal influenza vaccination programs for people of all age groups, which is creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza vaccine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on vaccine type, technology, age group and route of administration.
Breakup by Vaccine Type:
Quadrivalent
Trivalent
Breakup by Technology:
Egg-based
Cell-based
Breakup by Age Group:
Pediatric
Adult
Breakup by Route of Administration:
Injection
Nasal Spray
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, CSL Limited, Daiichi Sankyo Company Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and SINOVAC.
Key Questions Answered in This Report:
How has the global influenza vaccine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global influenza vaccine market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the age group?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global influenza vaccine market and who are the key players?
What is the degree of competition in the industry?
Influenza vaccines, also known as flu shots, provide protection against various types of influenza viruses. They are available in several options, including inactivated influenza vaccine [IIV], recombinant influenza vaccine [RIV], and live attenuated influenza vaccine (LAIV). Their effectiveness can vary, depending on the patient's age and health status. Presently, governments of numerous countries have mandated immunization against influenza among children between six months and five years of age. This is escalating the need for influenza vaccines to reduce the high risk of developing severe flu complications and hospitalization among infants around the world.
Influenza Vaccine Market Trends:
The rising prevalence of diabetes, cancer, anemia, obesity, immune deficiencies, human immunodeficiency virus (HIV), metabolic diseases, kidney disease, neurological disorder, and chronic heart and lung disorders, such as bronchopulmonary dysplasia, cystic fibrosis, and asthma, is increasing the risk of developing influenza. This acts as a major factor bolstering the market growth. In addition, children under five years of age are usually at a high risk of complications from high fever, convulsions, and pneumonia. This, in confluence with growing concerns among parents about the well-being of their children, is positively influencing the demand for influenza vaccines. Moreover, as immune systems decline with age, the rising geriatric population worldwide is catalyzing the demand for influenza vaccines to prevent serious illness, the need for hospitalization, and the possibility of a heart attack. Several vaccines are also available that help boost immune response in adults over sixty-five years. Besides this, health agencies of numerous countries are introducing free seasonal influenza vaccination programs for people of all age groups, which is creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza vaccine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on vaccine type, technology, age group and route of administration.
Breakup by Vaccine Type:
Quadrivalent
Trivalent
Breakup by Technology:
Egg-based
Cell-based
Breakup by Age Group:
Pediatric
Adult
Breakup by Route of Administration:
Injection
Nasal Spray
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, CSL Limited, Daiichi Sankyo Company Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and SINOVAC.
Key Questions Answered in This Report:
How has the global influenza vaccine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global influenza vaccine market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the age group?
What is the breakup of the market based on the route of administration?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global influenza vaccine market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFLUENZA VACCINE MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY VACCINE TYPE
6.1 Quadrivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Trivalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Egg-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY AGE GROUP
8.1 Pediatric
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Adult
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
9.1 Injection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Nasal Spray
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AstraZeneca plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 CSL Limited
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Daiichi Sankyo Company Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Emergent BioSolutions Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Gamma Vaccines Pty Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Merck & Co. Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Novartis AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Pfizer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sanofi
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 SINOVAC
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFLUENZA VACCINE MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY VACCINE TYPE
6.1 Quadrivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Trivalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 Egg-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY AGE GROUP
8.1 Pediatric
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Adult
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY ROUTE OF ADMINISTRATION
9.1 Injection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Nasal Spray
9.2.1 Market Trends
9.2.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AstraZeneca plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 CSL Limited
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Daiichi Sankyo Company Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Emergent BioSolutions Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Gamma Vaccines Pty Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Merck & Co. Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Novartis AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Pfizer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sanofi
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 SINOVAC
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
LIST OF TABLES
Table 1: Global: Influenza Vaccine Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Influenza Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2022-2027
Table 3: Global: Influenza Vaccine Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Influenza Vaccine Market Forecast: Breakup by Age Group (in Million US$), 2022-2027
Table 5: Global: Influenza Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 6: Global: Influenza Vaccine Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Influenza Vaccine Market: Competitive Structure
Table 8: Global: Influenza Vaccine Market: Key Players
Table 1: Global: Influenza Vaccine Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Influenza Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2022-2027
Table 3: Global: Influenza Vaccine Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Influenza Vaccine Market Forecast: Breakup by Age Group (in Million US$), 2022-2027
Table 5: Global: Influenza Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 6: Global: Influenza Vaccine Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Influenza Vaccine Market: Competitive Structure
Table 8: Global: Influenza Vaccine Market: Key Players
LIST OF FIGURES
Figure 1: Global: Influenza Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Influenza Vaccine Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Influenza Vaccine Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Influenza Vaccine Market: Breakup by Vaccine Type (in %), 2021
Figure 5: Global: Influenza Vaccine Market: Breakup by Technology (in %), 2021
Figure 6: Global: Influenza Vaccine Market: Breakup by Age Group (in %), 2021
Figure 7: Global: Influenza Vaccine Market: Breakup by Route of Administration (in %), 2021
Figure 8: Global: Influenza Vaccine Market: Breakup by Region (in %), 2021
Figure 9: Global: Influenza Vaccine (Quadrivalent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Influenza Vaccine (Quadrivalent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Influenza Vaccine (Trivalent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Influenza Vaccine (Trivalent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Influenza Vaccine (Egg-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Influenza Vaccine (Egg-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Influenza Vaccine (Cell-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Influenza Vaccine (Cell-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Influenza Vaccine (Pediatric) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Influenza Vaccine (Pediatric) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Influenza Vaccine (Adult) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Influenza Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Influenza Vaccine (Injection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Influenza Vaccine (Injection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Influenza Vaccine (Nasal Spray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Influenza Vaccine (Nasal Spray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: North America: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: North America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: United States: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: United States: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Canada: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Canada: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Asia-Pacific: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Asia-Pacific: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: China: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: China: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Japan: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Japan: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: India: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: India: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: South Korea: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: South Korea: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Australia: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Australia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Indonesia: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Indonesia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Europe: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Europe: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Germany: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Germany: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: France: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: France: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: United Kingdom: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: United Kingdom: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Italy: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Italy: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Spain: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Spain: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Russia: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Russia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Latin America: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Latin America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Brazil: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Brazil: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Mexico: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Mexico: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Middle East and Africa: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Middle East and Africa: Influenza Vaccine Market: Breakup by Country (in %), 2021
Figure 73: Middle East and Africa: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Influenza Vaccine Industry: SWOT Analysis
Figure 75: Global: Influenza Vaccine Industry: Value Chain Analysis
Figure 76: Global: Influenza Vaccine Industry: Porter's Five Forces Analysis
Figure 1: Global: Influenza Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Influenza Vaccine Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Influenza Vaccine Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Influenza Vaccine Market: Breakup by Vaccine Type (in %), 2021
Figure 5: Global: Influenza Vaccine Market: Breakup by Technology (in %), 2021
Figure 6: Global: Influenza Vaccine Market: Breakup by Age Group (in %), 2021
Figure 7: Global: Influenza Vaccine Market: Breakup by Route of Administration (in %), 2021
Figure 8: Global: Influenza Vaccine Market: Breakup by Region (in %), 2021
Figure 9: Global: Influenza Vaccine (Quadrivalent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Influenza Vaccine (Quadrivalent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Influenza Vaccine (Trivalent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Influenza Vaccine (Trivalent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Influenza Vaccine (Egg-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Influenza Vaccine (Egg-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Influenza Vaccine (Cell-based) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Influenza Vaccine (Cell-based) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Influenza Vaccine (Pediatric) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Influenza Vaccine (Pediatric) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Influenza Vaccine (Adult) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Influenza Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Influenza Vaccine (Injection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Influenza Vaccine (Injection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Influenza Vaccine (Nasal Spray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Influenza Vaccine (Nasal Spray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: North America: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: North America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: United States: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: United States: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Canada: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Canada: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Asia-Pacific: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Asia-Pacific: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: China: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: China: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Japan: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Japan: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: India: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: India: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: South Korea: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: South Korea: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Australia: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Australia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Indonesia: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Indonesia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Europe: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Europe: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Germany: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Germany: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: France: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: France: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: United Kingdom: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: United Kingdom: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Italy: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Italy: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Spain: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Spain: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Russia: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Russia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Latin America: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Latin America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Brazil: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Brazil: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Mexico: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Mexico: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Middle East and Africa: Influenza Vaccine Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Middle East and Africa: Influenza Vaccine Market: Breakup by Country (in %), 2021
Figure 73: Middle East and Africa: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Influenza Vaccine Industry: SWOT Analysis
Figure 75: Global: Influenza Vaccine Industry: Value Chain Analysis
Figure 76: Global: Influenza Vaccine Industry: Porter's Five Forces Analysis
